More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde

1. A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. 2. The method was used to test inhibition of human and mouse CYP2A enzymes by three phenylethylamine derivatives 2- (p -tolyl)-ethylamine, amphetamine, 2-phenylethylamine...

Full description

Saved in:
Bibliographic Details
Published inXenobiotica Vol. 33; no. 5; pp. 529 - 539
Main Authors Rahnasto, M., Raunio, H., Poso, A., Juvonen, R. O.
Format Journal Article
LanguageEnglish
Published London Informa UK Ltd 01.05.2003
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 1. A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. 2. The method was used to test inhibition of human and mouse CYP2A enzymes by three phenylethylamine derivatives 2- (p -tolyl)-ethylamine, amphetamine, 2-phenylethylamine and benzaldehyde, and two of its derivatives, 4-methylbenzaldehyde and 4-methoxybenzaldehyde. 3. The benzaldehyde derivatives were more potent inhibitors of CYP2A5 than the phenylethylamines. The K ic value of 4-methylbenzaldehyde was 3.4 µ M and for 4-methoxybenzaldehyde it was 0.86 µ M for CYP2A5. 4. Amphetamine is a weak inhibitor of CYP2A6, whereas benzaldehyde is a suicide inhibitor with K inact = 0.16 min − 1 and K I = 18 µ M. The K ic values of 2-phenylethylamine, 2- (p -tolyl)-ethylamine, 4-methylbenzaldehyde and 4-methoxybenzaldehyde were 1.13, 0.23, 0.36 and 0.73 µ M for CYP2A6, respectively. 5. Novel potent inhibitors were found for CYP2A6 and, except for 4-methoxybenzaldehyde, all the compounds inhibited CYP2A5 and CYP2A6 enzymes differentially. These data add to the refinement of CYP2A enzyme active sites and provide chemical leads for developing novel chemical inhibitors of the CYP2A6 enzyme.
AbstractList A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. The method was used to test inhibition of human and mouse CYP2A enzymes by three phenylethylamine derivatives 2-(p-tolyl)-ethylamine, amphetamine, 2-phenylethylamine and benzaldehyde, and two of its derivatives, 4-methylbenzaldehyde and 4-methoxybenzaldehyde. The benzaldehyde derivatives were more potent inhibitors of CYP2A5 than the phenylethylamines. The K sub(ic) value of 4-methylbenzaldehyde was 3.4 mu M and for 4-methoxybenzaldehyde it was 0.86 mu M for CYP2A5. Amphetamine is a weak inhibitor of CYP2A6, whereas benzaldehyde is a suicide inhibitor with K sub(inact) = 0.16 min super(m1) and K sub(l) = 18 mu M. The K sub(ic) values of 2-phenylethylamine, 2-(p-tolyl)-ethylamine, 4-methylbenzaldehyde and 4-methoxybenzaldehyde were 1.13, 0.23, 0.36 and 0.73 mu M for CYP2A6, respectively. Novel potent inhibitors were found for CYP2A6 and, except for 4-methoxybenzaldehyde, all the compounds inhibited CYP2A5 and CYP2A6 enzymes differentially. These data add to the refinement of CYP2A enzyme active sites and provide chemical leads for developing novel chemical inhibitors of the CYP2A6 enzyme.
1. A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. 2. The method was used to test inhibition of human and mouse CYP2A enzymes by three phenylethylamine derivatives 2-(p-tolyl)-ethylamine, amphetamine, 2-phenylethylamine and benzaldehyde, and two of its derivatives, 4-methylbenzaldehyde and 4-methoxybenzaldehyde. 3. The benzaldehyde derivatives were more potent inhibitors of CYP2A5 than the phenylethylamines. The K(ic) value of 4-methylbenzaldehyde was 3.4 micro M and for 4-methoxybenzaldehyde it was 0.86 micro M for CYP2A5. 4. Amphetamine is a weak inhibitor of CYP2A6, whereas benzaldehyde is a suicide inhibitor with K(inact) = 0.16 min(-1) and K(I) = 18 micro M. The K(ic) values of 2-phenylethylamine, 2-(p-tolyl)-ethylamine, 4-methylbenzaldehyde and 4-methoxybenzaldehyde were 1.13, 0.23, 0.36 and 0.73 micro M for CYP2A6, respectively. 5. Novel potent inhibitors were found for CYP2A6 and, except for 4-methoxybenzaldehyde, all the compounds inhibited CYP2A5 and CYP2A6 enzymes differentially. These data add to the refinement of CYP2A enzyme active sites and provide chemical leads for developing novel chemical inhibitors of the CYP2A6 enzyme.
1. A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. 2. The method was used to test inhibition of human and mouse CYP2A enzymes by three phenylethylamine derivatives 2- (p -tolyl)-ethylamine, amphetamine, 2-phenylethylamine and benzaldehyde, and two of its derivatives, 4-methylbenzaldehyde and 4-methoxybenzaldehyde. 3. The benzaldehyde derivatives were more potent inhibitors of CYP2A5 than the phenylethylamines. The K ic value of 4-methylbenzaldehyde was 3.4 µ M and for 4-methoxybenzaldehyde it was 0.86 µ M for CYP2A5. 4. Amphetamine is a weak inhibitor of CYP2A6, whereas benzaldehyde is a suicide inhibitor with K inact = 0.16 min − 1 and K I = 18 µ M. The K ic values of 2-phenylethylamine, 2- (p -tolyl)-ethylamine, 4-methylbenzaldehyde and 4-methoxybenzaldehyde were 1.13, 0.23, 0.36 and 0.73 µ M for CYP2A6, respectively. 5. Novel potent inhibitors were found for CYP2A6 and, except for 4-methoxybenzaldehyde, all the compounds inhibited CYP2A5 and CYP2A6 enzymes differentially. These data add to the refinement of CYP2A enzyme active sites and provide chemical leads for developing novel chemical inhibitors of the CYP2A6 enzyme.
Author Raunio, H.
Rahnasto, M.
Poso, A.
Juvonen, R. O.
Author_xml – sequence: 1
  givenname: M.
  surname: Rahnasto
  fullname: Rahnasto, M.
  organization: Department of Pharmacology and Toxicology, University of Kuopio, POB 1627, 70211 Kuopio, Finland
– sequence: 2
  givenname: H.
  surname: Raunio
  fullname: Raunio, H.
  organization: Department of Pharmacology and Toxicology, University of Kuopio, POB 1627, 70211 Kuopio, Finland
– sequence: 3
  givenname: A.
  surname: Poso
  fullname: Poso, A.
  organization: Department of Pharmacology and Toxicology, University of Kuopio, POB 1627, 70211 Kuopio, Finland
– sequence: 4
  givenname: R. O.
  surname: Juvonen
  fullname: Juvonen, R. O.
  organization: Department of Pharmacology and Toxicology, University of Kuopio, POB 1627, 70211 Kuopio, Finland
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14805817$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12746108$$D View this record in MEDLINE/PubMed
BookMark eNp9kE9v1DAQxS1URLeFT4CEfIFbwH_ijXMAqVpRQCqCAxw4RRNnrLhK7MV2isKBz15Xu6hCQp2Lx6Pfe5p5Z-TEB4-EPOfsNWeavWGsbrVQTHJWSqu2aR-RDZfbbaVaoU_I5o6oClKfkrOUrgu15UI8IadcNPW2mGzIn88hIt2HjD5T50fXu-yCp8HScZnB092Pr-JiS_NY-jksCQ8TRdH_XmekYLK7KRpMtF_pgNHdQJmUb7HYj-jXCfO4TjA7X2g_0L4oYRpwXAd8Sh5bmBI-O77n5Pvl-2-7j9XVlw-fdhdXlVGyyZXRNdbMstZK4Jb1vFdNa6E1tW6hllIIrqyQipseWdODMk3PBW-Y0pozBfKcvDr47mP4uWDK3eySwWkCj-WojmtdwpGqgPIAmhhSimi7fXQzxLXjrLuLvftP7EX14mi_9DMO95pjzgV4eQQgGZhsBG9cuudqXVblTeHeHTjnbYgz_ApxGroM6xTiX5F8eJO3_xiMCFMeDUTsrsMSfQn5wUtuAct3sko
CODEN XENOBH
CitedBy_id crossref_primary_10_1093_ntr_ntw002
crossref_primary_10_1038_sj_tpj_6500481
crossref_primary_10_1080_00498250701708539
crossref_primary_10_1007_s11095_008_9807_9
crossref_primary_10_1021_acs_chemrestox_9b00514
crossref_primary_10_1021_jm049536b
crossref_primary_10_1124_pr_57_1_3
crossref_primary_10_1016_j_bmc_2014_10_001
crossref_primary_10_1016_j_ejpb_2011_02_017
crossref_primary_10_1016_j_mce_2014_02_008
crossref_primary_10_3892_ol_2016_5317
crossref_primary_10_2133_dmpk_21_277
crossref_primary_10_3389_fnins_2022_1058254
crossref_primary_10_1016_j_exppara_2006_01_013
crossref_primary_10_1007_s40261_015_0354_y
crossref_primary_10_1124_jpet_107_133900
crossref_primary_10_1016_j_bmc_2011_09_054
crossref_primary_10_3109_00498254_2015_1048327
crossref_primary_10_1016_j_ejps_2012_09_018
crossref_primary_10_1089_cap_2017_0071
crossref_primary_10_1002_rcm_7218
crossref_primary_10_1007_s11095_013_1054_z
crossref_primary_10_3109_00498254_2013_783724
Cites_doi 10.1042/bj2670365
10.1016/0003-2697(85)90442-7
10.1023/A:1008102217770
10.1007/s002040050005
10.1111/j.1440-1681.1997.tb01807.x
10.1016/0278-6915(94)90078-7
10.1007/s00228-001-0396-3
10.1080/00498250210128693
10.1016/S0021-9258(18)50462-2
10.1016/0006-2952(93)90247-T
10.1073/pnas.93.10.4644
10.1111/j.1432-1033.1985.tb09156.x
10.1006/abio.1995.1278
10.1016/S0021-9258(18)43233-4
10.1080/004982500237848
10.1111/j.1476-5381.1995.tb13279.x
10.1097/00007691-200202000-00026
10.1021/bi9630568
10.1046/j.0306-5251.2001.01500.x
10.1016/S0021-9258(18)50153-8
10.1006/bbrc.1999.1182
10.1067/mcp.2000.103957
10.1006/abbi.1997.9964
10.1016/0378-4347(93)80016-W
10.1016/0003-2697(78)90245-2
10.1067/mcp.2000.107651
10.1021/bi00457a031
10.1016/S0300-483X(99)00200-0
ContentType Journal Article
Copyright 2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003
2003 INIST-CNRS
Copyright_xml – notice: 2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003
– notice: 2003 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U7
C1K
DOI 10.1080/0049825031000085979
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList Toxicology Abstracts
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1366-5928
EndPage 539
ExternalDocumentID 10_1080_0049825031000085979
12746108
14805817
11397003
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
.GJ
00X
03L
0BK
0R~
123
29R
36B
4.4
53G
5RE
5VS
AACCU
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABCRQ
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ACENM
ACFUF
ACGEJ
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
ADXPE
AECIN
AEGXH
AENEX
AEOZL
AEYQI
AFAUU
AFKVX
AFQCT
AFWLO
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJEBJ
AJWEG
AJXHO
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AWYRJ
BABNJ
BLEHA
BOHLJ
BVLLS
CAG
CCCUG
COF
CS3
DEIEU
DKSSO
DLVIE
DTRLO
DU5
DZHFC
EAP
EBC
EBD
EBS
EBX
EDH
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
J.N
JFOCU
KRBQP
KWAYT
KYCEM
L7B
LJTGL
M44
M4Z
MK0
O9-
OVD
QRXOQ
RNANH
RVRKI
SV3
TEORI
TFDNU
TFL
TFW
TUS
UHWXJ
V1S
ZGI
ZXP
~1N
~KM
ABXYU
IQODW
ABJNI
ABLIJ
ACIEZ
ALYBC
CGR
CUY
CVF
ECM
EIF
NPM
NUSFT
TBQAZ
TERGH
TUROJ
AAYXX
CITATION
7U7
C1K
ID FETCH-LOGICAL-c537t-c84e40f09f3a1f0b1b579fa9c489a4332215f2351cbe07ba5c7b12170588105a3
ISSN 0049-8254
IngestDate Fri Aug 16 00:50:48 EDT 2024
Fri Aug 23 03:07:48 EDT 2024
Sat Sep 28 08:39:59 EDT 2024
Sun Oct 22 16:04:31 EDT 2023
Tue Jun 13 19:49:44 EDT 2023
Tue Jul 04 19:20:51 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Vertebrata
Mammalia
Mouse
Animal
Coumarine derivatives
Cytochrome P450
Liver
Rodentia
Benzaldehyde
Enzyme inhibitor
In vitro
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c537t-c84e40f09f3a1f0b1b579fa9c489a4332215f2351cbe07ba5c7b12170588105a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 12746108
PQID 18800635
PQPubID 23462
PageCount 11
ParticipantIDs proquest_miscellaneous_18800635
crossref_primary_10_1080_0049825031000085979
pascalfrancis_primary_14805817
informaworld_taylorfrancis_310_1080_0049825031000085979
pubmed_primary_12746108
informahealthcare_journals_10_1080_0049825031000085979
PublicationCentury 2000
PublicationDate 2003-05-01
PublicationDateYYYYMMDD 2003-05-01
PublicationDate_xml – month: 05
  year: 2003
  text: 2003-05-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Xenobiotica
PublicationTitleAlternate Xenobiotica
PublicationYear 2003
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References LUDBROOK J (CIT0022) 1997; 24
CIT0012
COON M. J. (CIT0004) 1998; 26
LEWIS D. F. (CIT0020) 2002; 32
MILES J. S. (CIT0024) 1990; 267
KOENIGS L. L. (CIT0016) 1997; 25
WOOD A. W (CIT0041) 1979; 254
FUJITA K. (CIT0007) 2001; 29
HILLER D. L. (CIT0009) 1995; 227
VAN TEASEL, M., WALTERS, D. G., PRICE, R. J., LOVELL, D. P. and LAKE, B. G. (CIT0038) 1994; 32
INouE K. (CIT0010) 2000; 73
KIMONEN T. (CIT0013) 1995; 114
MAENPAA. J. (CIT0023) 1993; 45
DRAPER A. J. (CIT0006) 1997; 341
GREENLEE W. F. (CIT0008) 1978; 205
LANG M. A. (CIT0019) 1981; 256
AITIO A (CIT0001) 1978; 85
TYNDALE R. F. (CIT0036) 2001; 29
KITAGAWA K. (CIT0014) 1999; 262
ZHANG W. (CIT0043) 2001; 29
Poso A. (CIT0030) 2001; 15
VAZ A. D. (CIT0039) 1996; 93
YAMANO S. (CIT0042) 1990; 29
JUVONEN R. (CIT0011) 1985; 152
RAUNIO H. (CIT0032) 2001; 52
LAMIABLE D. (CIT0018) 1993; 620
WEN X. (CIT0040) 2002; 57
NAKAJIMA M. (CIT0026) 2000; 67
OSCARSON M (CIT0027) 2001; 29
SMITH P. K. (CIT0034) 1985; 150
KITZ R. (CIT0015) 1962; 237
TAAVITSAINEN P. (CIT0035) 2001; 29
TYNDALE R. F. (CIT0037) 2002; 24
RANER G. M. (CIT0031) 1997; 36
CIT0005
PELKONEN O. (CIT0028) 2000; 144
SELLERS E. M. (CIT0033) 2000; 68
References_xml – volume: 25
  start-page: 1407
  year: 1997
  ident: CIT0016
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: KOENIGS L. L.
– volume: 267
  start-page: 365
  year: 1990
  ident: CIT0024
  publication-title: Biochemical Journal
  doi: 10.1042/bj2670365
  contributor:
    fullname: MILES J. S.
– volume: 150
  start-page: 76
  year: 1985
  ident: CIT0034
  publication-title: Analytical Biochemistry
  doi: 10.1016/0003-2697(85)90442-7
  contributor:
    fullname: SMITH P. K.
– volume: 15
  start-page: 195
  year: 2001
  ident: CIT0030
  publication-title: Journal of Computer-Aided Molecular Design
  doi: 10.1023/A:1008102217770
  contributor:
    fullname: Poso A.
– volume: 73
  start-page: 532
  year: 2000
  ident: CIT0010
  publication-title: Archives of Toxicology
  doi: 10.1007/s002040050005
  contributor:
    fullname: INouE K.
– volume: 24
  start-page: 193
  year: 1997
  ident: CIT0022
  publication-title: Clinical and Experimental Pharmacology and Physiology
  doi: 10.1111/j.1440-1681.1997.tb01807.x
  contributor:
    fullname: LUDBROOK J
– volume: 32
  start-page: 387
  year: 1994
  ident: CIT0038
  publication-title: Food and Chemical Toxicology
  doi: 10.1016/0278-6915(94)90078-7
  contributor:
    fullname: VAN TEASEL, M., WALTERS, D. G., PRICE, R. J., LOVELL, D. P. and LAKE, B. G.
– volume: 57
  start-page: 799
  year: 2002
  ident: CIT0040
  publication-title: European Journal of Clinical Pharmacology
  doi: 10.1007/s00228-001-0396-3
  contributor:
    fullname: WEN X.
– volume: 32
  start-page: 547
  year: 2002
  ident: CIT0020
  publication-title: Xenobiotica
  doi: 10.1080/00498250210128693
  contributor:
    fullname: LEWIS D. F.
– volume: 254
  start-page: 5641
  year: 1979
  ident: CIT0041
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)50462-2
  contributor:
    fullname: WOOD A. W
– volume: 29
  start-page: 91
  year: 2001
  ident: CIT0027
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: OSCARSON M
– volume: 45
  start-page: 1035
  year: 1993
  ident: CIT0023
  publication-title: Biochemical Pharmacology
  doi: 10.1016/0006-2952(93)90247-T
  contributor:
    fullname: MAENPAA. J.
– volume: 93
  start-page: 4644
  year: 1996
  ident: CIT0039
  publication-title: Proceedings of the National Academy of Sciences, USA
  doi: 10.1073/pnas.93.10.4644
  contributor:
    fullname: VAZ A. D.
– volume: 152
  start-page: 38
  year: 1985
  ident: CIT0011
  publication-title: European Journal of Biochemistry
  doi: 10.1111/j.1432-1033.1985.tb09156.x
  contributor:
    fullname: JUVONEN R.
– volume: 227
  start-page: 251
  year: 1995
  ident: CIT0009
  publication-title: Analytical Biochemistry
  doi: 10.1006/abio.1995.1278
  contributor:
    fullname: HILLER D. L.
– volume: 256
  start-page: 12058
  year: 1981
  ident: CIT0019
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)43233-4
  contributor:
    fullname: LANG M. A.
– ident: CIT0012
  doi: 10.1080/004982500237848
– volume: 114
  start-page: 832
  year: 1995
  ident: CIT0013
  publication-title: British Journal of Pharmacology
  doi: 10.1111/j.1476-5381.1995.tb13279.x
  contributor:
    fullname: KIMONEN T.
– volume: 24
  start-page: 163
  year: 2002
  ident: CIT0037
  publication-title: Therapeutic Drug Monitoring
  doi: 10.1097/00007691-200202000-00026
  contributor:
    fullname: TYNDALE R. F.
– volume: 36
  start-page: 4895
  year: 1997
  ident: CIT0031
  publication-title: Biochemistry
  doi: 10.1021/bi9630568
  contributor:
    fullname: RANER G. M.
– volume: 29
  start-page: 548
  year: 2001
  ident: CIT0036
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: TYNDALE R. F.
– volume: 29
  start-page: 897
  year: 2001
  ident: CIT0043
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: ZHANG W.
– volume: 52
  start-page: 357
  year: 2001
  ident: CIT0032
  publication-title: British Journal of Clinical Pharmacology
  doi: 10.1046/j.0306-5251.2001.01500.x
  contributor:
    fullname: RAUNIO H.
– volume: 237
  start-page: 3245
  year: 1962
  ident: CIT0015
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)50153-8
  contributor:
    fullname: KITZ R.
– volume: 29
  start-page: 983
  year: 2001
  ident: CIT0007
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: FUJITA K.
– volume: 262
  start-page: 146
  year: 1999
  ident: CIT0014
  publication-title: Biochemical and Biophysical Research Communications
  doi: 10.1006/bbrc.1999.1182
  contributor:
    fullname: KITAGAWA K.
– volume: 26
  start-page: 1190
  year: 1998
  ident: CIT0004
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: COON M. J.
– volume: 67
  start-page: 57
  year: 2000
  ident: CIT0026
  publication-title: Clinical Pharmacology and Therapeutics
  doi: 10.1067/mcp.2000.103957
  contributor:
    fullname: NAKAJIMA M.
– ident: CIT0005
– volume: 341
  start-page: 47
  year: 1997
  ident: CIT0006
  publication-title: Archives of Biochemistry and Biophysics
  doi: 10.1006/abbi.1997.9964
  contributor:
    fullname: DRAPER A. J.
– volume: 205
  start-page: 596
  year: 1978
  ident: CIT0008
  publication-title: Journal of Pharmacology and Experi-mental Therapeutics
  contributor:
    fullname: GREENLEE W. F.
– volume: 620
  start-page: 273
  year: 1993
  ident: CIT0018
  publication-title: Journal of Chromatography
  doi: 10.1016/0378-4347(93)80016-W
  contributor:
    fullname: LAMIABLE D.
– volume: 85
  start-page: 488
  year: 1978
  ident: CIT0001
  publication-title: Analytical Biochemistry
  doi: 10.1016/0003-2697(78)90245-2
  contributor:
    fullname: AITIO A
– volume: 68
  start-page: 35
  year: 2000
  ident: CIT0033
  publication-title: Clinical Pharmacology and Therapeutics
  doi: 10.1067/mcp.2000.107651
  contributor:
    fullname: SELLERS E. M.
– volume: 29
  start-page: 1322
  year: 1990
  ident: CIT0042
  publication-title: Biochemistry
  doi: 10.1021/bi00457a031
  contributor:
    fullname: YAMANO S.
– volume: 29
  start-page: 217
  year: 2001
  ident: CIT0035
  publication-title: Drug Metabolism and Disposition
  contributor:
    fullname: TAAVITSAINEN P.
– volume: 144
  start-page: 139
  year: 2000
  ident: CIT0028
  publication-title: Toxicology
  doi: 10.1016/S0300-483X(99)00200-0
  contributor:
    fullname: PELKONEN O.
SSID ssj0006122
Score 1.8098379
Snippet 1. A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. 2. The method was used to test...
A rapid 96-well plate assay method was developed and validated to measure liver microsomal coumarin 7-hydroxylation in vitro. The method was used to test...
SourceID proquest
crossref
pubmed
pascalfrancis
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 529
SubjectTerms Analytical, structural and metabolic biochemistry
Animals
Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors
Benzaldehydes - chemistry
Benzaldehydes - pharmacology
Binding, Competitive
Biological and medical sciences
Cytochrome P-450 CYP2A6
Cytochrome P450 Family 2
Dose-Response Relationship, Drug
Enzyme Inhibitors - pharmacology
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Humans
Inhibitory Concentration 50
Kinetics
Mice
Microsomes, Liver - enzymology
Mixed Function Oxygenases - antagonists & inhibitors
Oxidoreductases
Phenethylamines - chemistry
Phenethylamines - pharmacology
Regression Analysis
Structure-Activity Relationship
Title More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde
URI https://www.tandfonline.com/doi/abs/10.1080/0049825031000085979
https://www.ncbi.nlm.nih.gov/pubmed/12746108
https://search.proquest.com/docview/18800635
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9owELbo7qG9VNvtiz62PlR7CUEksePkyNKu0Eq0aMVK9BTZwRFIbVgtASl76C_pj-04dh5Ai7q9RGgUm1jzeTwzHn9G6GNCaMBDb2ZL5ksb4g3HDohwbV-6Lifg4JNE7eiOvvjDG3I1pdNW61ejammdiW58_8dzJf-jVZCBXtUp2QdotuoUBPAb9AtP0DA8_0nHo-WdtG6XmdrPX6TzhVhU_l-Rmx98G7t931LZcUuF-FJLqCXT-_yHJtLYFJSqygudwSdvCh7worxDFX_loNV5DqBRvqhKsQtoyb_P5DyfbdUQTWWq-JyyRuXPNZ-nfFXc0mSNurV0nS4K2bCSjZcrfdimklytN8tUG8TrrvW1u5WbaFQClvaWhLaKQfVqo02s5_s2Dc2RcGODNRmGwRptGFRq8iF6baaa-GjP7Jd1kiSEP-vpPYsAQqWwXuXKnf2dxa8qSXQqrtS9Th6hY5eFFEL74_7Fp4vLaqUH71Cz0ZtRlqxWirt9v5stz-fE8OLOqyq_Ha5cVaTLVzBPE33Byt8joMITmpygpyaEwX2Nx2eoJdNT9HhQ3hx4is7Hmg897-BJfbxv1cHneFwzpefP0U8FYKwBjGsA42WCCwBjDWCsAIwLAGsJxRrAuAYwFjluAFh1sQtgDADGTQC_QDeXnyeDoW0uBLFj6rHMjgMiSS_phYnHnaQnHEFZmPAwBqPCFREf-K-J61EnFrLHBKcxE46rCKOCAOII7r1ERynA9zXCnEgmGbwWJ-CkSs5FTB1FzE3BOAk3aKNOqazoVvO-RAcg0kb-nkIjYylWhxuyptajrMjTGZ1H3sGWZ1sAqT-TBDBgh7XRhxIxEQBAbQTyVIKuIsXBCKEJbaNXGkh1W5epCxiCNw8b_lv0pJ7-79BRdreW78FZz8SZmTO_AW2B338
link.rule.ids 315,786,790,27957,27958
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=More+potent+inhibition+of+human+CYP2A6+than+mouse+CYP2A5+enzyme+activities+by+derivatives+of+phenylethylamine+and+benzaldehyde&rft.jtitle=Xenobiotica&rft.au=Rahnasto%2C+M.&rft.au=Raunio%2C+H.&rft.au=Poso%2C+A.&rft.au=Juvonen%2C+R.+O.&rft.date=2003-05-01&rft.issn=0049-8254&rft.eissn=1366-5928&rft.volume=33&rft.issue=5&rft.spage=529&rft.epage=539&rft_id=info:doi/10.1080%2F0049825031000085979&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_0049825031000085979
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0049-8254&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0049-8254&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0049-8254&client=summon